Aspekton – 30 ml Syrup
Aspekton Syrup Bottle 30ml is an herbal cough syrup used to relieve irritation in the throat and airways.
It contains ivy leaf extract, which helps to loosen mucus and support easier breathing.
🌱 What It Is
Aspekton is a plant-based cough remedy in liquid form, typically made from ivy leaf extract (Hedera helix). It is used to relieve productive cough by loosening mucus and making it easier to expel. The natural saponins in ivy leaf have expectorant, bronchodilatory, and soothing effects on the respiratory system.
✅ Key Benefits
-
Relieves cough – loosens and clears mucus from the airways.
-
Supports breathing – improves airflow by reducing congestion.
-
Plant-based formula – gentle, natural ivy extract.
-
Suitable for children and adults – safe herbal alternative.
💊 Use & Dosage
-
Adults & adolescents: typically 15–20 drops, 3 times daily.
-
Children: dosage depends on age; usually fewer drops as per leaflet instructions.
-
Can be taken directly or diluted in a small amount of water or tea.
⚠️ Safety & Precautions
-
For oral use only.
-
Not suitable for children under 2 years without medical advice.
-
Do not exceed the recommended dose.
-
Mild digestive upset may occur in rare cases.
📦 Product Details
-
Active ingredient: Ivy leaf extract (Hedera helix)
-
Form: Oral drops
-
Bottle size: 30 ml
-
Indications: Productive cough, bronchitis, mucus buildup
🛒 Buy Aspekton 30 ml
Soothe your cough naturally with Aspekton drops—a trusted herbal solution for respiratory relief. Available now at zanzona.com with EU-wide delivery.
Pack size: 30 ml bottle.
- Relieves cough and throat irritation
- Helps loosen mucus and ease expectoration
- Herbal-based formula, suitable for adults and children
Dosage: Adults and adolescents – 5 ml 2–3 times daily.
Children’s dosage should follow doctor’s or pharmacist’s advice.
Shake well before use. Keep out of reach of children.
Store at room temperature, away from direct sunlight.
Buy Aspekton Syrup Bottle 30ml
Order Aspekton Syrup Bottle 30ml

Reviews
There are no reviews yet.